BMO Capital raised the firm’s price target on UiPath to $15 from $14 but keeps a Market Perform rating on the shares. The company generated largely in line Q2 results, which is positive after last Q’s challenges and the firm’s conviction in achieving estimates is moving modestly higher, though BMO also has “lingering concerns” about UiPath’s ongoing transition to an automation company, including the competitive dynamics, the analyst tells investors in a research note.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PATH: